Abstract
2-Substituted 3-aroylquinolin-4(1H)-ones, prepared through a palladium-catalyzed carbonylative cyclization of N-(2-iodoaryl)enaminones, proved to inhibit efficiently the Hedgehog pathway through direct antagonism of the wild-type and drug-resistant form of the Smoothened receptor. Notably, these compounds repressed the Hh-dependent growth events and the proliferation of tumor cells with aberrant activation of the Hh pathway, which plays a crucial role in development and tumorigenesis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Catalysis
-
Cell Line
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Drug Design*
-
Hedgehog Proteins / antagonists & inhibitors*
-
Hedgehog Proteins / metabolism
-
Humans
-
Mice
-
Models, Molecular
-
Neoplasms / drug therapy
-
Neoplasms / metabolism
-
Palladium / chemistry
-
Quinolones / chemical synthesis
-
Quinolones / chemistry*
-
Quinolones / pharmacology*
-
Signal Transduction / drug effects*
Substances
-
Antineoplastic Agents
-
Hedgehog Proteins
-
Quinolones
-
Palladium